Biostar Microtech International Corp (2399) Fair Value & Analysis
Technology · TW · Market cap 8.5B TWD
Fair value as of: Jun 24, 2026
Analysis
Biostar Microtech International Corp (2399) currently trades at 54.30 TWD, while our model-based Fair Value estimate is 93.34 TWD — implying the stock looks roughly 71.9% undervalued today. We read business quality at 95/100 (high quality), in the Technology sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.
About the company
Biostar Microtech International Corp. engages in the design, development, manufacture, and marketing of various networking solutions in Taiwan and internationally. The company provides edge computing, industrial automation, EV chargers, digital signage, POS and KIOSK systems, PC (MB/VGA), AI workstations, and human-machine interface solutions. It also offers industrial PCs, motherboards, graphics cards, SSDs, memory, desktop PCs, peripherals, and accessories. In addition, the company provides electronic technology consulting services; and motherboard, industrial computer, and graphics cards. Its products are used in gaming, creator, home, office, and education applications. Biostar Microtech International Corp. was founded in 1979 and is based in New Taipei City, Taiwan.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is Biostar Microtech International Corp (2399) undervalued?
What is the fair value of 2399?
What is the quality score of 2399?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.